To unfreeze and release funding for grant agreements of the National Institutes of Health, prohibit termination of such agreements for active and ongoing research, require the inclusion of termination clauses in such agreements, and prohibit termination of such agreements for no longer effectuating program goals or agency priorities.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a grant, compliance mandate provision: 2. Releasing NIH grant funding, expands a grant, compliance mandate, definition change provision: 3, and expands a grant, compliance mandate, delegation of rulemaking provision: 4. It relies on grants, compliance mandates, definition changes, and delegation of rulemaking. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a grant, compliance mandate provision: 2. Releasing NIH grant funding.
- Expands a grant, compliance mandate, definition change provision: 3.
- Expands a grant, compliance mandate, delegation of rulemaking provision: 4.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a grant, compliance mandate provision: 2. Releasing NIH grant funding, expands a grant, compliance mandate, definition change provision: 3, and expands a grant, compliance mandate, delegation of rulemaking provision: 4.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a grant, compliance mandate provision: 2. Releasing NIH grant funding, expands a grant, compliance mandate, definition change provision: 3, and expands a grant, compliance mandate, delegation of rulemaking provision: 4.
Policy Domains
Sponsors
Legislative Progress
IntroducedMrs. Watson Coleman (for herself, Mr. Thompson of Mississippi, Mr. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology